| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
0-30 |
GENE |
denotes |
Angiotensin-converting enzymes |
| T1 |
32-35 |
GENE |
denotes |
ACE |
| T2 |
37-41 |
GENE |
denotes |
ACE2 |
| T3 |
48-56 |
VAR |
denotes |
variants |
| T4 |
61-69 |
DISEASE |
denotes |
COVID-19 |
| T5 |
70-77 |
CPA |
denotes |
outcome |
| T6 |
105-115 |
REG |
denotes |
implicated |
| T7 |
123-135 |
MPA |
denotes |
pathogenesis |
| T8 |
139-147 |
DISEASE |
denotes |
COVID-19 |
| T9 |
156-160 |
GENE |
denotes |
ACE2 |
| T10 |
168-185 |
MPA |
denotes |
cellular receptor |
| T11 |
206-216 |
MPA |
denotes |
expression |
| T12 |
224-228 |
GENE |
denotes |
ACE2 |
| T13 |
240-248 |
REG |
denotes |
regulate |
| T14 |
265-279 |
MPA |
denotes |
susceptibility |
| T15 |
283-292 |
DISEASE |
denotes |
infection |
| T16 |
327-331 |
GENE |
denotes |
ACE1 |
| T17 |
336-340 |
GENE |
denotes |
ACE2 |
| T18 |
341-349 |
MPA |
denotes |
activity |
| T19 |
359-369 |
REG |
denotes |
implicated |
| T20 |
377-389 |
MPA |
denotes |
pathogenesis |
| T21 |
393-413 |
DISEASE |
denotes |
respiratory diseases |
| T22 |
424-428 |
REG |
denotes |
play |
| T23 |
431-435 |
REG |
denotes |
role |
| T24 |
443-451 |
MPA |
denotes |
severity |
| T25 |
455-463 |
DISEASE |
denotes |
COVID-19 |
| T26 |
476-485 |
GENE |
denotes |
ACE1/ACE2 |
| T27 |
491-504 |
VAR |
denotes |
polymorphisms |
| T28 |
515-525 |
REG |
denotes |
associated |
| T29 |
543-557 |
DISEASE |
denotes |
cardiovascular |
| T30 |
543-580 |
DISEASE |
denotes |
cardiovascular and pulmonary diseases |
| T31 |
562-580 |
DISEASE |
denotes |
pulmonary diseases |
| T32 |
602-612 |
REG |
denotes |
contribute |
| T33 |
620-627 |
CPA |
denotes |
outcome |
| T34 |
631-639 |
DISEASE |
denotes |
COVID-19 |
| T35 |
656-664 |
DISEASE |
denotes |
COVID-19 |
| T36 |
749-753 |
GENE |
denotes |
ACE1 |
| T37 |
754-772 |
VAR |
denotes |
insertion/deletion |
| T38 |
777-781 |
GENE |
denotes |
ACE2 |
| T39 |
782-804 |
VAR |
denotes |
rs2285666 polymorphism |
| T40 |
923-927 |
GENE |
denotes |
ACE2 |
| T41 |
971-986 |
DISEASE |
denotes |
Severe COVID-19 |
| T42 |
978-986 |
DISEASE |
denotes |
COVID-19 |
| T43 |
991-1001 |
REG |
denotes |
associated |
| T44 |
1007-1019 |
DISEASE |
denotes |
hypertension |
| T45 |
1045-1057 |
DISEASE |
denotes |
hypertension |
| T46 |
1071-1092 |
DISEASE |
denotes |
hypercholesterolaemia |
| T47 |
1114-1121 |
GENE |
denotes |
ACE1-DD |
| T48 |
1122-1130 |
VAR |
denotes |
genotype |
| T49 |
1180-1192 |
DISEASE |
denotes |
hypertension |
| T50 |
1328-1338 |
REG |
denotes |
predictors |
| T51 |
1342-1350 |
CPA |
denotes |
severity |
| T52 |
1356-1360 |
GENE |
denotes |
ACE2 |
| T53 |
1361-1373 |
VAR |
denotes |
polymorphism |
| T54 |
1382-1392 |
REG |
denotes |
associated |
| T55 |
1402-1417 |
MPA |
denotes |
disease outcome |
| T56 |
1423-1427 |
GENE |
denotes |
ACE2 |
| T57 |
1465-1473 |
VAR |
denotes |
variants |
| T58 |
1485-1492 |
REG |
denotes |
explain |
| T59 |
1496-1505 |
POSREG |
denotes |
increased |
| T60 |
1525-1533 |
DISEASE |
denotes |
COVID-19 |
| T61 |
1553-1560 |
POSREG |
denotes |
adverse |
| T62 |
1561-1568 |
CPA |
denotes |
outcome |
| T63 |
1572-1580 |
DISEASE |
denotes |
COVID-19 |
| T64 |
1585-1595 |
REG |
denotes |
associated |
| T65 |
1614-1626 |
DISEASE |
denotes |
hypertension |
| T66 |
1628-1648 |
DISEASE |
denotes |
hypercholesterolemia |
| T67 |
1657-1661 |
GENE |
denotes |
ACE1 |
| T68 |
1662-1670 |
VAR |
denotes |
genotype |
| T69 |
1700-1708 |
GENE |
denotes |
ACE1-I/D |
| T70 |
1715-1724 |
REG |
denotes |
influence |
| T71 |
1725-1733 |
DISEASE |
denotes |
COVID-19 |
| T72 |
1734-1742 |
MPA |
denotes |
severity |
| T73 |
1752-1758 |
REG |
denotes |
effect |
| T74 |
1763-1772 |
REG |
denotes |
dependent |
| T75 |
1780-1792 |
DISEASE |
denotes |
hypertensive |
| R0 |
T0 |
T3 |
ThemeOf |
Angiotensin-converting enzymes,variants |
| R1 |
T1 |
T3 |
ThemeOf |
ACE,variants |
| R10 |
T11 |
T13 |
ThemeOf |
expression,regulate |
| R11 |
T12 |
T10 |
ThemeOf |
ACE2,cellular receptor |
| R12 |
T12 |
T11 |
ThemeOf |
ACE2,expression |
| R13 |
T14 |
T13 |
ThemeOf |
susceptibility,regulate |
| R14 |
T15 |
T14 |
ThemeOf |
infection,susceptibility |
| R15 |
T15 |
T13 |
ThemeOf |
infection,regulate |
| R16 |
T18 |
T19 |
ThemeOf |
activity,implicated |
| R17 |
T20 |
T19 |
ThemeOf |
pathogenesis,implicated |
| R18 |
T21 |
T20 |
ThemeOf |
respiratory diseases,pathogenesis |
| R19 |
T20 |
T22 |
ThemeOf |
pathogenesis,play |
| R2 |
T2 |
T3 |
ThemeOf |
ACE2,variants |
| R20 |
T20 |
T23 |
ThemeOf |
pathogenesis,role |
| R21 |
T24 |
T20 |
ThemeOf |
severity,pathogenesis |
| R22 |
T21 |
T19 |
ThemeOf |
respiratory diseases,implicated |
| R23 |
T21 |
T22 |
ThemeOf |
respiratory diseases,play |
| R24 |
T21 |
T23 |
ThemeOf |
respiratory diseases,role |
| R25 |
T23 |
T22 |
ThemeOf |
role,play |
| R26 |
T24 |
T19 |
ThemeOf |
severity,implicated |
| R27 |
T24 |
T22 |
ThemeOf |
severity,play |
| R28 |
T24 |
T23 |
ThemeOf |
severity,role |
| R29 |
T25 |
T24 |
ThemeOf |
COVID-19,severity |
| R3 |
T7 |
T6 |
ThemeOf |
pathogenesis,implicated |
| R30 |
T25 |
T19 |
ThemeOf |
COVID-19,implicated |
| R31 |
T25 |
T22 |
ThemeOf |
COVID-19,play |
| R32 |
T25 |
T23 |
ThemeOf |
COVID-19,role |
| R33 |
T26 |
T27 |
ThemeOf |
ACE1/ACE2,polymorphisms |
| R34 |
T27 |
T28 |
CauseOf |
polymorphisms,associated |
| R35 |
T27 |
T32 |
CauseOf |
polymorphisms,contribute |
| R36 |
T27 |
T33 |
CauseOf |
polymorphisms,outcome |
| R37 |
T29 |
T28 |
ThemeOf |
cardiovascular,associated |
| R38 |
T29 |
T32 |
ThemeOf |
cardiovascular,contribute |
| R39 |
T31 |
T28 |
ThemeOf |
pulmonary diseases,associated |
| R4 |
T8 |
T7 |
ThemeOf |
COVID-19,pathogenesis |
| R40 |
T31 |
T32 |
ThemeOf |
pulmonary diseases,contribute |
| R41 |
T33 |
T32 |
ThemeOf |
outcome,contribute |
| R42 |
T34 |
T33 |
ThemeOf |
COVID-19,outcome |
| R43 |
T34 |
T32 |
ThemeOf |
COVID-19,contribute |
| R44 |
T36 |
T37 |
ThemeOf |
ACE1,insertion/deletion |
| R45 |
T36 |
T39 |
ThemeOf |
ACE1,rs2285666 polymorphism |
| R46 |
T38 |
T37 |
ThemeOf |
ACE2,insertion/deletion |
| R47 |
T38 |
T39 |
ThemeOf |
ACE2,rs2285666 polymorphism |
| R48 |
T41 |
T43 |
ThemeOf |
Severe COVID-19,associated |
| R49 |
T48 |
T43 |
CauseOf |
genotype,associated |
| R5 |
T8 |
T6 |
ThemeOf |
COVID-19,implicated |
| R50 |
T51 |
T50 |
ThemeOf |
severity,predictors |
| R51 |
T52 |
T53 |
ThemeOf |
ACE2,polymorphism |
| R52 |
T53 |
T54 |
CauseOf |
polymorphism,associated |
| R53 |
T53 |
T55 |
CauseOf |
polymorphism,disease outcome |
| R54 |
T55 |
T54 |
ThemeOf |
disease outcome,associated |
| R55 |
T56 |
T57 |
ThemeOf |
ACE2,variants |
| R56 |
T57 |
T58 |
CauseOf |
variants,explain |
| R57 |
T57 |
T59 |
CauseOf |
variants,increased |
| R58 |
T60 |
T58 |
ThemeOf |
COVID-19,explain |
| R59 |
T60 |
T59 |
ThemeOf |
COVID-19,increased |
| R6 |
T9 |
T10 |
ThemeOf |
ACE2,cellular receptor |
| R60 |
T62 |
T61 |
ThemeOf |
outcome,adverse |
| R61 |
T63 |
T62 |
ThemeOf |
COVID-19,outcome |
| R62 |
T62 |
T64 |
ThemeOf |
outcome,associated |
| R63 |
T63 |
T61 |
ThemeOf |
COVID-19,adverse |
| R64 |
T63 |
T64 |
ThemeOf |
COVID-19,associated |
| R65 |
T67 |
T68 |
ThemeOf |
ACE1,genotype |
| R66 |
T68 |
T61 |
CauseOf |
genotype,adverse |
| R67 |
T68 |
T64 |
CauseOf |
genotype,associated |
| R68 |
T71 |
T70 |
ThemeOf |
COVID-19,influence |
| R69 |
T71 |
T72 |
ThemeOf |
COVID-19,severity |
| R7 |
T9 |
T11 |
ThemeOf |
ACE2,expression |
| R70 |
T71 |
T73 |
ThemeOf |
COVID-19,effect |
| R71 |
T71 |
T74 |
ThemeOf |
COVID-19,dependent |
| R72 |
T72 |
T70 |
ThemeOf |
severity,influence |
| R73 |
T72 |
T73 |
ThemeOf |
severity,effect |
| R74 |
T72 |
T74 |
ThemeOf |
severity,dependent |
| R75 |
T73 |
T74 |
ThemeOf |
effect,dependent |
| R8 |
T11 |
T10 |
ThemeOf |
expression,cellular receptor |
| R9 |
T10 |
T13 |
ThemeOf |
cellular receptor,regulate |
